DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
GTS-21 is an investigational drug.
There have been 8 clinical trials for GTS-21. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2011.
The most common disease conditions in clinical trials are Tourette Syndrome, Syndrome, and Schizophrenia. The leading clinical trial sponsors are CoMentis, China Medical University Hospital, and Children's Hospital Medical Center, Cincinnati.
There are eighteen US patents protecting this investigational drug and ninety-nine international patents.
Recent Clinical Trials for GTS-21
|Selective Microbiota Transplantation for Tourette's Syndrome||Faming Zhang||Phase 1/Phase 2|
|Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder||China Medical University Hospital||Phase 2|
|Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions||University of Florida||Phase 2|
Top disease conditions for GTS-21
Top clinical trial sponsors for GTS-21
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|GTS-21||Start Trial||Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists||The Feinstein Institute for Medical Research (Manhasset, NY)||Start Trial|
|GTS-21||Start Trial||Inhibition of inflammation using .alpha. 7 receptor-binding cholinergic agonists||The Feinstein Institute for Medical Research (Manhasset, NY)||Start Trial|
|GTS-21||Start Trial||Treatment of inflammation using .alpha.7 receptor-binding cholinergic agonists||The Feinstein Institute for Medical Research (Manhasset, NY)||Start Trial|
|GTS-21||Start Trial||Amide derivatives as positive allosteric modulators and methods of use thereof||Abbott Laboratories (Abbott Park, IL)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|